Chlorotoxin

未知生产厂商

Chlorotoxin is under investigation in clinical trial NCT00733798 (A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma).

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Chlorotoxin is under investigation in clinical trial NCT00733798 (A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma).

技术标识符

CAS 编号: 163515-35-3
UNII ID: 06UV5RFW57

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

CHIMERIC ANTIGEN RECEPTORS CONTAINING A CHLOROTOXIN DOMAIN
EP 3362470 B1申请人: HOPE CITY优先权: 2015
CN
EP
US
WO
7 件公开
CHLOROTOXIN POLYPEPTIDES AND CONJUGATES AND USES THEREOF
EP 3238735 A1申请人: MORPHOTEK INC优先权: 2010
EP
US
7 件公开
CHLOROTOXIN CONJUGATES AND METHODS OF USE THEREOF
EP 3046572 B1申请人: BLAZE BIOSCIENCE INC优先权: 2013
CN
EP
US
WO
6 件公开
CHIMERIC CHLOROTOXIN RECEPTORS
EP 3551657 B1申请人: UAB RES FOUND优先权: 2016
EP
US
WO
6 件公开
Treatment of metastatic tumors
- US 8227439 B2
  申请人: O'NEILL ALISON优先权: 2009
  US
  5 件公开
- CN 102438646 A
  申请人: TRANSMOLECULAR INC优先权: 2009
  CN
Systemic Administration of Chlorotoxin Agents for the Diagnosis and Treatment of Tumors
US 2010215575 A1申请人: TRANSMOLECULAR INC优先权: 2007
CN
EP
US
WO
4 件公开
MULTIVALENT CHLOROTOXIN CHIMERIC ANTIGEN RECEPTORS
- EP 4281087 A4
  申请人: IN8BIO INC优先权: 2021
  EP
  US
  WO
  4 件公开
- CN 117202913 A
  申请人: IN8 BIO INC优先权: 2021
  CN
Diagnosis and treatment of neuroectodermal tumors
US 7678759 B2申请人: TRANSMOLECULAR INC优先权: 2003
US
4 件公开
Chlorotoxin-labeled nanoparticle compositions and methods for targeting primary brain tumors
US 2007154965 A1申请人: ZHANG MIQIN优先权: 2006
US
4 件公开
Inhibition of angiogenesis
US 8470607 B2申请人: JACOBY DOUGLAS B优先权: 2008
CN
US
3 件公开

药物

Chlorotoxin

概览

专利

Treatment of metastatic tumors

MULTIVALENT CHLOROTOXIN CHIMERIC ANTIGEN RECEPTORS